Skip to main content
SpringerLink
Log in

Letter to the editors

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Weiss RB, Sarosy G, Clagett-Carr K, Russo M, Leyland-Jones B (1986) Anthracycline analogs: The past, present, and future (A Review). Cancer Chemother Pharmacol 18: 185

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Groupe Hospitalier Paul-Brousse, Institut de Cancérologie et d'Immunogénétique, F-94800, Villejuif, France

    Georges Mathé

  2. Walter Reed Army Medical Center, Washington, DC, USA

    Raymond B. Weiss

  3. National Cancer Institute, Bethesda, MD, USA

    Brian Leyland-Jones

Authors
  1. Georges Mathé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. J. McElwain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raymond B. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brian Leyland-Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathé, G., Carter, S.K., McElwain, T.J. et al. Letter to the editors. Cancer Chemother. Pharmacol. 19, 350 (1987). https://doi.org/10.1007/BF00261488

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00261488

Keywords

Search

Navigation